<?xml version="1.0" encoding="UTF-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"><url><loc>https://insights.citeline.com/hbw-insight/beauty/business/deals/loreal-closes-kering-beaute-clorox-wraps-purell-beauty-deal-roundup-HBW7BOP37RBETNZULTPTIKSN7U/</loc><lastmod>2026-04-04T00:48:24.159Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-04T00:48:24.159Z</news:publication_date><news:title><![CDATA[L’Oréal Closes Kering Beauté, Clorox Wraps Purell; Beauty Deal Roundup]]></news:title></news:news><image:image><image:loc>https://insights.citeline.com/resizer/yh-avIEGk3splBMZtHc0NaIwSMU=/cloudfront-us-east-1.images.arcpublishing.com/norstella/EH7B2YMGSNDY7GX4HC3LHKU7SE.jpg</image:loc></image:image></url><url><loc>https://insights.citeline.com/companies/hasselt-university</loc><lastmod>2026-04-04T00:06:41.933Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-04T00:06:41.933Z</news:publication_date><news:title><![CDATA[Hasselt University]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/exponential-biotherapies-inc</loc><lastmod>2026-04-04T00:06:23.798Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-04T00:06:23.798Z</news:publication_date><news:title><![CDATA[Exponential Biotherapies, Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/seger-surgical-solutions-ltd</loc><lastmod>2026-04-04T00:06:17.912Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-04T00:06:17.912Z</news:publication_date><news:title><![CDATA[Seger Surgical Solutions Ltd.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/hebei-renhe-yikang-pharmaceutical-co-ltd</loc><lastmod>2026-04-04T00:06:11.987Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-04T00:06:11.987Z</news:publication_date><news:title><![CDATA[Hebei Renhe Yikang Pharmaceutical Co., Ltd.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/fraunhofer-institute-for-toxicology-and-experimental-medicine-item</loc><lastmod>2026-04-04T00:06:06.014Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-04T00:06:06.014Z</news:publication_date><news:title><![CDATA[Fraunhofer Institute for Toxicology and Experimental Medicine ITEM]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/lumito-ab-publ</loc><lastmod>2026-04-04T00:05:59.948Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-04T00:05:59.948Z</news:publication_date><news:title><![CDATA[Lumito AB]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/neumirna-therapeutics-aps</loc><lastmod>2026-04-04T00:05:47.861Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-04T00:05:47.861Z</news:publication_date><news:title><![CDATA[NEUmiRNA Therapeutics ApS]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/180-therapeutics</loc><lastmod>2026-04-04T00:05:41.622Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-04T00:05:41.622Z</news:publication_date><news:title><![CDATA[180 Therapeutics]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/atb-therapeutics</loc><lastmod>2026-04-04T00:05:35.574Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-04T00:05:35.574Z</news:publication_date><news:title><![CDATA[ATB Therapeutics]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/nua-surgical</loc><lastmod>2026-04-04T00:05:29.713Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-04T00:05:29.713Z</news:publication_date><news:title><![CDATA[Nua Surgical]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/medshine-discovery-inc</loc><lastmod>2026-04-04T00:05:23.51Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-04T00:05:23.51Z</news:publication_date><news:title><![CDATA[Medshine Discovery, Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/valanx-biotech</loc><lastmod>2026-04-04T00:05:17.522Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-04T00:05:17.522Z</news:publication_date><news:title><![CDATA[VALANX Biotech]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/biomissile</loc><lastmod>2026-04-04T00:05:11.542Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-04T00:05:11.542Z</news:publication_date><news:title><![CDATA[Biomissile]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/aion-healthspan-inc</loc><lastmod>2026-04-04T00:05:05.765Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-04T00:05:05.765Z</news:publication_date><news:title><![CDATA[AION Healthspan, Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/santa-ana-bio</loc><lastmod>2026-04-04T00:04:59.493Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-04T00:04:59.493Z</news:publication_date><news:title><![CDATA[Santa Ana Bio]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/adularia-ag</loc><lastmod>2026-04-04T00:04:53.51Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-04T00:04:53.51Z</news:publication_date><news:title><![CDATA[Adularia AG]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/tr1x-inc</loc><lastmod>2026-04-04T00:04:47.401Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-04T00:04:47.401Z</news:publication_date><news:title><![CDATA[Tr1X, Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/neobiosis-llc</loc><lastmod>2026-04-04T00:04:41.587Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-04T00:04:41.587Z</news:publication_date><news:title><![CDATA[Neobiosis, LLC]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/beijing-health-guard-biotechnology</loc><lastmod>2026-04-04T00:04:35.355Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-04T00:04:35.355Z</news:publication_date><news:title><![CDATA[Beijing Health Guard Biotechnology]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/university-of-pittsburgh-medical-center-upmc</loc><lastmod>2026-04-04T00:04:29.446Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-04T00:04:29.446Z</news:publication_date><news:title><![CDATA[University of Pittsburgh Medical Center (UPMC)]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/aviceda-therapeutics</loc><lastmod>2026-04-04T00:04:23.275Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-04T00:04:23.275Z</news:publication_date><news:title><![CDATA[Aviceda Therapeutics]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/belite-bio-inc</loc><lastmod>2026-04-04T00:04:17.317Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-04T00:04:17.317Z</news:publication_date><news:title><![CDATA[Belite Bio, Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/salspera-llc</loc><lastmod>2026-04-04T00:04:11.234Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-04T00:04:11.234Z</news:publication_date><news:title><![CDATA[Salspera, Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/nuvig-therapeutics-inc</loc><lastmod>2026-04-04T00:04:05.184Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-04T00:04:05.184Z</news:publication_date><news:title><![CDATA[Nuvig Therapeutics, Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/evqlv-inc</loc><lastmod>2026-04-04T00:03:59.166Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-04T00:03:59.166Z</news:publication_date><news:title><![CDATA[EVQLV, Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/therini-bio-inc</loc><lastmod>2026-04-04T00:03:53.641Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-04T00:03:53.641Z</news:publication_date><news:title><![CDATA[Therini Bio, Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/engimmune-therapeutics-ag</loc><lastmod>2026-04-04T00:03:47.144Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-04T00:03:47.144Z</news:publication_date><news:title><![CDATA[Engimmune Therapeutics AG]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/fibrobiologics-inc</loc><lastmod>2026-04-04T00:03:41.1Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-04T00:03:41.1Z</news:publication_date><news:title><![CDATA[FibroBiologics, Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/keymed-biosciences-inc</loc><lastmod>2026-04-04T00:03:35.147Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-04T00:03:35.147Z</news:publication_date><news:title><![CDATA[Keymed Biosciences Inc. ]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/nephrogen-llc</loc><lastmod>2026-04-04T00:03:31.445Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-04T00:03:31.445Z</news:publication_date><news:title><![CDATA[Nephrogen LLC]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/loreal-sa</loc><lastmod>2026-04-04T00:03:22.89Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-04T00:03:22.89Z</news:publication_date><news:title><![CDATA[L'Oreal SA]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/laboratorio-italiano-biochimico-farmaceutico-lisapharma-spa</loc><lastmod>2026-04-04T00:03:17.119Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-04T00:03:17.119Z</news:publication_date><news:title><![CDATA[Laboratorio Italiano Biochimico Farmaceutico Lisapharma Spa]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/toolgen-inc</loc><lastmod>2026-04-04T00:03:11.028Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-04T00:03:11.028Z</news:publication_date><news:title><![CDATA[ToolGen Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/suzhou-zhongkai-bio-pharmaceuticals-co-ltd</loc><lastmod>2026-04-04T00:03:04.916Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-04T00:03:04.916Z</news:publication_date><news:title><![CDATA[Suzhou Zhongkai Bio-Pharmaceuticals Co. Ltd.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/nubiyota-llc</loc><lastmod>2026-04-04T00:02:58.862Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-04T00:02:58.862Z</news:publication_date><news:title><![CDATA[NuBiyota LLC]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/theracryf</loc><lastmod>2026-04-04T00:02:52.677Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-04T00:02:52.677Z</news:publication_date><news:title><![CDATA[TheraCryf]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/ascendis-pharma-as</loc><lastmod>2026-04-04T00:02:46.653Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-04T00:02:46.653Z</news:publication_date><news:title><![CDATA[Ascendis Pharma A/S]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/uppsala-university</loc><lastmod>2026-04-04T00:02:40.742Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-04T00:02:40.742Z</news:publication_date><news:title><![CDATA[Uppsala University]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/alveron-pharma</loc><lastmod>2026-04-04T00:02:34.66Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-04T00:02:34.66Z</news:publication_date><news:title><![CDATA[Alveron Pharma]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/timmune-biotech-inc</loc><lastmod>2026-04-04T00:02:28.664Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-04T00:02:28.664Z</news:publication_date><news:title><![CDATA[Timmune Biotech Inc]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/neuroptika</loc><lastmod>2026-04-04T00:02:19.641Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-04T00:02:19.641Z</news:publication_date><news:title><![CDATA[Neuroptika Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/bentley-innomed-gmbh</loc><lastmod>2026-04-04T00:02:07.731Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-04T00:02:07.731Z</news:publication_date><news:title><![CDATA[Bentley Innomed GmbH]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/childrens-hospital-of-eastern-ontario</loc><lastmod>2026-04-04T00:01:55.679Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-04T00:01:55.679Z</news:publication_date><news:title><![CDATA[Children's Hospital of Eastern Ontario]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/valeo-pharma-inc</loc><lastmod>2026-04-04T00:01:43.569Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-04T00:01:43.569Z</news:publication_date><news:title><![CDATA[Valeo Pharma Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/stada-arzneimittel-ag</loc><lastmod>2026-04-04T00:01:31.828Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-04T00:01:31.828Z</news:publication_date><news:title><![CDATA[STADA Arzneimittel AG]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/smiths-group-plc</loc><lastmod>2026-04-04T00:01:07.8Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-04T00:01:07.8Z</news:publication_date><news:title><![CDATA[Smiths Group plc]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/medac-gmbh</loc><lastmod>2026-04-04T00:00:55.721Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-04T00:00:55.721Z</news:publication_date><news:title><![CDATA[medac GmbH]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/zevra-therapeutics-inc</loc><lastmod>2026-04-04T00:00:43.645Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-04T00:00:43.645Z</news:publication_date><news:title><![CDATA[Zevra Therapeutics, Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/atyr-pharma-inc</loc><lastmod>2026-04-04T00:00:32.333Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-04T00:00:32.333Z</news:publication_date><news:title><![CDATA[aTyr Pharma, Inc.]]></news:title></news:news></url></urlset>